Prostate stromal cells express biologically relevant levels of FGF2, and therefore the increase in FGF2 in the bone microenvironment may promote prostate cancer cell growth by providing a prostate-like environment (Kwabi-Addo et al. 2004, Pecqueux et al. 2018). The gene discussed is FGF2; the disease is Familial prostate cancer.